Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
10,001 - 25,000 - Monthly Reach
Unique listeners across all episodes (30 days)
25,001 - 75,000 - Active Followers
Loyal subscribers who consistently listen
15,001 - 40,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Not detected.
Recent guests
Recent episodes
Driving Progress in AML
Apr 23, 2026
34m 20s
Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment
Apr 13, 2026
34m 15s
Optimizing Outcomes in Myeloma
Mar 24, 2026
40m 03s
Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology
Mar 3, 2026
39m 55s
What’s New and What’s Next in CLL
Feb 17, 2026
39m 19s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 4/23/26 | Driving Progress in AML✨ | acute myeloid leukemiaAML+3 | David Sallman Md | menin inhibitorsMoffitt Cancer Center+3 | TampaFL | menin inhibitorstreatment selection+3 | — | 34m 20s | |
| 4/13/26 | Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment✨ | survivorshiphealthcare support+2 | Matthew Loscalzo | Loss and Grief: Personal Stories of Doctors and Other Healthcare Professionals by Linda KAPOS+4 | City of HopeDuarte+1 | clinical insightshealthcare professionals+1 | — | 34m 15s | |
| 3/24/26 | Optimizing Outcomes in Myeloma✨ | MyelomaBlood Cancer+2 | Amy Pierre Msn Anp-BcPeter Voorhees Md | MSNANP-BC+13 | New YorkNY+4 | treatmentpatient outcomes+1 | — | 40m 03s | |
| 3/3/26 | Strategies to Navigate Expanded Access (Compassionate Use) in Treating Pediatric Oncology✨ | Expanded AccessCompassionate Use+2 | Julie Guillot | University of AlabamaBlood Cancer United+11 | BirminghamAL+2 | pediatric AMLadvocacy+1 | — | 39m 55s | |
| 2/17/26 | What’s New and What’s Next in CLL✨ | chronic lymphocytic leukemiadiagnostic considerations+3 | Brad Kahl Md | Siteman Cancer CenterDivision of Oncology+10 | St. Louis MOSt. Louis+1 | CLLhematology+3 | — | 39m 19s | |
| 2/4/26 | Guiding Fertility Care for Adolescents and Young Adults✨ | fertility careadolescents+2 | Pam Simon Msn Cpnp CponH Irene Su Md Msce | CPONStanford Adolescent and Young Adult Cancer Program+13 | Palo AltoCA+1 | — | — | 37m 46s | |
| 1/23/26 | Building Resilience: Burnout & Compassion Fatigue Tools for HCPs✨ | burnoutcompassion fatigue+3 | Chelsey Winegar | Intermountain HealthLCSW+2 | MurrayUT | healthcaremental health+2 | — | 36m 41s | |
| 1/13/26 | Key Insights from Attending ASH 2025✨ | hematologic malignanciesmultiple myeloma+5 | Lore Gruenbaum Phd | Blood Cancer UnitedResearch Blood Cancer United+4 | WashingtonDC | ASH 2025Blood Cancer United+2 | — | 33m 51s | |
| 12/17/25 | Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know✨ | equitable cancer caresocial determinants of health+2 | Raymond Mailhot Md Mph | University of MiamiMPH Department of Radiation Oncology+3 | MiamiFL | healthcare professionalscommunication strategies+2 | — | 30m 48s | |
| 11/20/25 | Hairy Cell Leukemia: Strategies for Improved Patient Outcomes✨ | hairy cell leukemiadiagnostic work-up+6 | Paul J Hampel Md | Mayo ClinicDivision of Hematology+2 | RochesterMN | patient outcomescancer treatment+1 | — | 40m 10s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 11/6/25 |  Managing CML: What HCPs Need to Know | Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on October 23, 2025 Michael J. Mauro, MD Director, Chronic Myeloid Leukemia Program Professor of Medicine, Leukemia Service Memorial Sloan Kettering Cancer Center New York, NY Tune in for this expert-led discussion with Dr. Michael Mauro from Memorial Sloan Kettering Cancer Center on the evolving management of chronic myeloid leukemia (CML) in the era of tyrosine kinase inhibitors (TKIs) and newly approved FDA therapies. Dr. Mauro explores how TKIs have transformed prognosis, key factors guiding initial therapy selection, and best practices for managing treatment-related side effects. He also shares updates on TKI discontinuation criteria, long-term monitoring, and a forward look at ongoing trials and emerging therapeutic advances shaping the future of CML care. Gain actionable insights to enhance patient outcomes today! | — | ||||||
| 10/10/25 | Understanding MRD: Insights for clinical practice and patient care | Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA Recorded on September 25, 2025 Rahul Banerjee, MD, FACP Assistant Professor Fred Hutchinson Cancer Center Seattle, WA In this episode, Dr. Rahul Banerjee from Fred Hutchinson Cancer Center in Seattle, WA, discusses the evolving role of measurable residual disease (MRD) in hematologic malignancies. He explores what MRD is, how assays are used and interpreted, and its impact across the disease continuum. The conversation also covers MRD’s role in clinical trials, how to effectively explain MRD to patients, practical considerations for testing in community settings, and key education resources for both healthcare professionals and patients. Tune in today to gain practical insights you can apply in your daily practice! This episode is supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics. | — | ||||||
| 9/19/25 | Pediatric Acute Leukemias: Focus on clinical trials for treatment | Ann Collins, PA, Blood Cancer United, Washington, DC, Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC, Sarah K. Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA Recorded on September 9, 2025 Ann Collins, PA Project Leader, Pediatric Acute Leukemia Master Clinical Trial (PedAL) Blood Cancer United Washington, DC Kelly Laschinger, MSN, RN, CPNP, CPHON Director, Clinical Trial Support Center Blood Cancer United Washington, DC Sarah K. Tasian, MD Blood Cancer United PedAL Master Clinical Trial Lead Associate Professor of Pediatrics, University of Pennsylvania School of Medicine Chief of Hematologic Malignancies Program, Children’s Hospital of Philadelphia Philadelphia, PA Join us for our first episode as Blood Cancer United! In this episode, Dr. Sarah Tasian, from Children’s Hospital of Philadelphia, and Ann Collins and Kelly Laschinger, from Blood Cancer United, join us for an in-depth discussion on pediatric acute leukemias. The conversation delves into the latest therapies, treatment challenges, and the complex realities of long-term survivorship. We also explore the groundbreaking Blood Cancer United Pediatric Acute Leukemia Master Clinical Trial (PedAL), its bold vision, global collaboration, and unified approach to data collection. Valuable clinical trial resources and strategies to support patients, families, and healthcare professionals are also shared. Tune in today! | — | ||||||
| 7/9/25 | Charting the Course of ALL: From Diagnosis to Advances | Catherine Lai, MD, MPH, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA Recorded on June 27, 2025 Catherine Lai, MD, MPH Associate Professor Physician Leader, Leukemia Clinical Research Unit University of Pennsylvania Perelman Center for Advanced Medicine Philadelphia, PA In this episode, Dr. Catherine Lai, from the University of Pennsylvania’s Perelman Center for Advanced Medicine, joins us to discuss the current landscape of adult acute lymphoblastic leukemia (ALL) treatment. She highlights recent advances in frontline and relapsed therapies, the critical role of measurable residual disease (MRD), and the use of immunotherapy and targeted treatments. Dr. Lai further explores transplant considerations, management of side effects, and tailored approaches for B-cell and T-cell ALL. She also emphasizes patient-centered care, including strategies for end-of-life discussions and shared decision-making. Tune in today for expert insights and practical takeaways on the evolving future of ALL care! | — | ||||||
| 6/12/25 | Strategies and Advances in AML | Uma Borate, MBBS, MS, The Ohio State University, Columbus, OH Recorded on May 27, 2025 Uma Borate, MBBS, MS Associate Professor, Division of Hematology Acute Leukemia Clinical Research Disease Group Leader The Ohio State University Columbus, OH What’s changing in acute myeloid leukemia (AML)? Join Dr. Uma Borate from The Ohio State University in Columbus, Ohio, as she dives into emerging breakthroughs in AML biology, including molecular drivers, menin inhibitors, and the challenges of developing bispecifics and CAR T-cell therapies. She also shares updates from the LLS Beat AML® Master Clinical Trial and ongoing clinical trials, and reflects on the evolving treatment landscape across age groups. Don’t miss this dynamic conversation packed with expertise and hope for the future of AML! | — | ||||||
| 5/29/25 | Advancing Care in Myeloproliferative Neoplasms (MPNs) | Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH Recorded on May 13, 2025 Aaron Gerds, MD, MS Associate Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University School of Medicine Medical Director Case Comprehensive Cancer Center Clinical Research Office Cleveland, OH In this episode, Dr. Aaron Gerds from the Cleveland Clinic explores the intricacies of Myeloproliferative Neoplasms (MPNs), from diagnosis and monitoring to treatment goals and the latest therapeutic advances. Dr. Gerds discusses emerging therapies, the significance of clinical trials, strategies for managing side effects and long-term effects, and valuable resources for healthcare professionals, patients, and families. Tune in today for expert insights on MPNs! This episode is supported by GSK plc and Karyopharm Therapeutics. | — | ||||||
| 5/13/25 | A Collaborative Approach to Survivorship Care | A Collaborative Approach to Survivorship Care Tessa Faye Flores, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY … A Collaborative Approach to Survivorship CareRead More » | — | ||||||
| 4/30/25 | MDS: Patient-Centered Approaches to Diagnosis and Treatment | Mikkael A. Sekeres, MD, MS, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL Recorded on April 17, 2025 Mikkael A. Sekeres, MD, MS Chief, Division of Hematology Professor of Medicine Sylvester Comprehensive Cancer Center University of Miami Miami, FL Join us with Dr. Mikkael Sekeres of the University of Miami Sylvester Comprehensive Cancer Center as he explores the complexities of diagnosing and treating Myelodysplastic Syndromes (MDS), including “watch and wait.” Through case-based discussion, he highlights advances in high-risk MDS management, from novel targeted therapies to stem cell transplantation and clinical trials. Dr. Sekeres also shares strategies for managing side effects and emphasizes the importance of multidisciplinary care in improving patient outcomes. Tune in to gain valuable insights on MDS today! | — | ||||||
| 4/18/25 | Optimizing Care for Pediatric Blood Cancer | Jeffrey Magee, MD, PhD, Washington University School of Medicine, St. Louis, MO Recorded on April 3, 2025 Jeffrey Magee, MD, PhD Elizabeth H. and James S. McDonnell III Professor of Pediatrics Director, McDonnell Pediatric Cancer Center Division of Pediatric Hematology and Oncology Washington University School of Medicine St. Louis, MO In this episode, we sit down with Dr. Jeffrey Magee from the McDonald Pediatric Cancer Center at the Washington University School of Medicine in St. Louis to discuss the evolving landscape of pediatric blood cancers. Reflecting on his work, Dr. Magee shares, “One of the things I really love about the job is that it operates right at the interface between the science and the professional practice of medicine.” He examines groundbreaking advances bringing new hope to children and their families, from novel therapies and CAR T-cell therapy to the crucial role of clinical trials. Dr. Magee also speaks candidly about the challenges of delivering difficult news and shares compassionate strategies for supporting families through their toughest moments. Join us for this insightful and informative conversation on the future of pediatric blood cancer care today! Additional LLS Resource: Stars Will Twinkle, The Sun Will Shine A three-book series and movie for kids with blood cancer. Follow Olivia and her family as she is diagnosed with leukemia, goes to the hospital for treatment, and returns to school. | — | ||||||
| 3/28/25 | Navigating Complex and Challenging Cases in Myeloma | Angela Dispenzieri, MD, Mayo Clinic, Rochester, MN Recorded on March 18, 2025 Angela Dispenzieri, MD Consultant, Division of Hematology Serene M. and Frances C. Durling Professor of Medicine and of Laboratory Medicine and Pathology Mayo Clinic Rochester, MN Join us as we dive into in the complex care of amyloid and myeloma with Dr. Angela Dispenzieri from Mayo Clinic Rochester, Minnesota. She explains the diagnosis and explores the differences between amyloid and myeloma. Discussion on treatment strategies for complex cases, side effects of therapies, and difficult conversations with patients, provide practical information on patient care. Tune in today to learn more about the complexities of myeloma. This episode is supported by GSK plc. | — | ||||||
| 3/13/25 | Beyond Burnout: Strategies for Empowering Healthcare Professionals | Guy Maytal, MD, Forge Health and Weill Cornell Medicine, New York Recorded on February 20, 2025 Guy Maytal, MD Chief Medical Officer, Forge Health White Plains, NY Clinical Assistant Professor of Psychiatry, Weill Cornell Medicine New York, NY In this episode, Dr. Guy Maytal, from Forge Health and Weill Cornell Medicine in New York, explores burnout and wellness in healthcare professionals, highlighting the difference between burnout and compassion fatigue. He shares valuable insights on recognizing these issues, while emphasizing the importance of connection, resilience, and self-care in preventing and overcoming burnout. Dr. Maytal also offers practical strategies for institutions to better support healthcare professionals. Tune in for the latest insights on healthcare professional wellness today! | — | ||||||
| 2/28/25 | Key Strategies for HCPs: Supporting Caregivers and Care Partners | Timothy Pearman, PhD, ABPP, Northwestern University Feinberg School of Medicine, Chicago, IL Recorded on February 6, 2025 Timothy Pearman, PhD, ABPP Director, Supportive Oncology Robert H. Lurie Comprehensive Cancer Center Professor, Department of Medical Social Sciences and Psychiatry & Behavioral Sciences Northwestern University Feinberg School of Medicine Chicago, IL Join us for an insightful episode featuring Dr. Timothy Pearman from Northwestern University, as he explores the critical role of caregivers and care partners to a patient’s healthcare team. Dr. Pearman discusses the challenges caregivers face, including burnout, relationship stress, and issues surrounding sex and intimacy. He also offers effective communication strategies to address these challenges and shares ways healthcare professionals can better educate and support caregivers. Tune in to this informative podcast for valuable insights and resources for caregivers! This episode is supported by Genentech, A Member of the Roche Group. | — | ||||||
| 2/14/25 | CAR-T in 2025: Advancements and the Road Ahead | Jason Westin, M.D., MS, FACP, MD Anderson Cancer Center, Houston, TX Recorded on January 21, 2025 Jason Westin, M.D., MS, FACP Professor, Department of Lymphoma & Myeloma Lead, Lymphoma & Myeloma Service Line Director, Lymphoma Clinical Research Section Chief, Aggressive and Indolent Lymphoma MD Anderson Cancer Center Houston, TX In this episode, Dr. Jason Westin from MD Anderson Cancer Center in Houston, Texas explores CAR T-cell therapy, covering both current and emerging indications. He highlights the educational needs of patients and caregivers, as well as the essential role of community and academic collaboration before and after treatment. Dr. Westin also discusses the use of minimal/measurable residual disease (MRD) in treatment planning, future directions of CAR-T, and ongoing clinical trials. Tune in to stay up-to-date on the latest advancements in CAR T-cell therapy! This episode is supported by Allogene Therapeutics, Bristol Myers Squibb, Johnson& Johnson & Legend Biotech, and Kite, a Gilead Company. | — | ||||||
| 1/31/25 | Exploring Cutaneous T-Cell Lymphoma | Jaehyuk (Jae) Choi, MD, Northwestern University Feinberg School of Medicine, Chicago, IL Recorded on January 7, 2025 Jaehyuk (Jae) Choi, MD Jack W. Graffin Associate Professor of Dermatology and of Biochemistry and Molecular Genetics Northwestern University Feinberg School of Medicine Chicago, IL In this episode, Dr. Jaehyuk Choi from Northwestern University, explores Cutaneous T-Cell Lymphoma (CTCL), covering key diagnostic tools, emerging therapies, and the importance of a multidisciplinary team approach. He delves into effective symptom management, including the psychosocial impact of pruritus, and discusses the latest ongoing research. Additionally, Dr. Choi highlights disparities in diagnosis, treatment access, and patient outcomes. Tune in today to gain valuable insights on this complex diagnosis! This episode is supported by Kyowa Kirin, Inc. | — | ||||||
| 1/17/25 | Highlights from Attending ASH 2024 | Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 19, 2024 Lee Greenberger, PhD Chief Scientific Officer and SVP The Leukemia & Lymphoma Society Rye Brook, NY In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, returns to provide information presented at the 66th American Society of Hematology (ASH) Annual Meeting, including updates in myeloma, leukemia, and lymphoma. Dr. Greenberger also discusses updates in blood cancer therapies, including nutrition, CAR T-cell therapy, and bispecifics. Tune in today! This episode is supported by Autolus Therapeutics. | — | ||||||
Showing 25 of 116
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.